Sorafenib Tosylate
C21H16ClF3N4O3·C7H8O3S
637.03
2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, mono(4-methylbenzenesulfonate);
4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N2-methylpyridine-2-carboxamide mono(4-methylbenzenesulfonate)
[475207-59-1] Sorafenib (free base) C21H16ClF3N4O3 464.83
[284461-73-0]
2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, mono(4-methylbenzenesulfonate);
4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N2-methylpyridine-2-carboxamide mono(4-methylbenzenesulfonate)
[475207-59-1] Sorafenib (free base) C21H16ClF3N4O3 464.83
[284461-73-0]
DEFINITION
Sorafenib Tosylate contains NLT 97.0% and NMT 102.0% of sorafenib tosylate (C21H16ClF3N4O3·C7H8O3S), calculated on the anhydrous and solvent-free basis.